29 reports

The global artificial pancreas device systems (APDS) market exhibited strong growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of 13.1% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect...

  • Diabetes Monitoring
  • World

Diabetes Monitoring Devices market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Diabetes Monitoring Devices Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Diabetes Monitoring Devices types, applications....

  • Diabetes Monitoring
  • World

Report Scope: The global diabetes monitoring devices market generally consists of the following devices: self-glucose monitoring devices, blood glucose meter devices, blood glucose test strips, lancets and lancet devices, continuous glucose monitoring devices, transmitters and receivers. This report does not include other...

  • Diabetes Monitoring
  • World
  • Health Expenditure

INTRODUCTION Diabetes is one of the seven leading causes of death and disability across the world. According to the World Health Organization (WHO), more than 1.6 million deaths are directly attributed to diabetes each year. In 2019, the global expenditure on diabetes treatment and disease management was estimated to be...

  • Diabetes Monitoring
  • World
  • APAC
  • Number Of Enterprises

Abstract: - Global Glucose Monitoring Devices Market to Reach $16.1 Billion by 2027 - Amid the COVID-19 crisis, the global market for Glucose Monitoring Devices estimated at US$10.8 Billion in the year 2020, is projected to reach a revised size of US$16.1 Billion by 2027, growing at a CAGR of 5.9% over the analysis...

  • Diabetes Monitoring
  • World
  • China
  • United States

This study covers the world outlook for diabetes monitoring, treatment, and drug delivery products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region,...

  • Diabetes Monitoring
  • Drug Delivery
  • World
  • Gross Domestic Product
  • Disposable Income

This study covers the world outlook for diabetes monitoring devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Diabetes Monitoring
  • World
  • Gross Domestic Product
  • Disposable Income

There is huge global interest in incorporating electronic functions into clothing and wearable devices for applications such as wearable sensing, healthcare, soft robotics and human computer interfaces. These areas will greatly benefit from developing electrical interconnects, sensors, transistors and circuits, lighting elements and power...

  • Apparel
  • Diabetes Monitoring
  • Wearables
  • Healthcare
  • Robotics
  • Capacitor
  • World

This study covers the latent demand outlook for diabetes monitoring, treatment, and drug delivery products across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question,...

  • Diabetes Monitoring
  • Drug Delivery
  • United States
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for diabetes monitoring, treatment, and drug delivery products across the states, union territories, and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 4,900 cities in India. For each city in question, the...

  • Diabetes Monitoring
  • Drug Delivery
  • India
  • United States
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for diabetes monitoring, treatment, and drug delivery products across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau),...

  • Diabetes Monitoring
  • Drug Delivery
  • China
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for diabetes monitoring devices across the states, union territories, and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 4,900 cities in India. For each city in question, the percent share the city is of...

  • Diabetes Monitoring
  • India
  • United States
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for diabetes monitoring devices across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter...

  • Diabetes Monitoring
  • China
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for diabetes monitoring devices across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the city...

  • Diabetes Monitoring
  • United States
  • Disposable Income
  • Purchasing Power Parity

Global Diabetes Devices Market: Scope and Methodology This report on the global diabetes devices market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The...

  • Diabetes
  • Diabetes Monitoring
  • World
  • Diabetes Prevalence
  • Life Expectancy

About Diabetes Care Devices Diabetes care devices are used to monitor and control the level of blood glucose. It includes SMBG meters, SMBG test strips, insulin pumps, insulin syringes. These are used to administer appropriate amount of insulin to the patient. Diabetes is a lifelong condition, which occurs due to inadequate production...

  • Diabetes Care
  • Insulin Delivery
  • Diabetes Monitoring
  • World
  • Diabetes Prevalence
  • Health Expenditure

Description Diabetes mellitus is a multifaceted disease that yields various approaches in terms of diagnosis, treatment and drug delivery. Products for maintenance and treatment of diabetes can be of high volume and low cost or of relatively low volume and high cost. The U.S. diabetes monitoring, treatment and drug delivery market...

  • Insulin
  • Diabetes Monitoring
  • United States
  • Diabetes Prevalence

Description The U.S. blood glucose meter market can be segmented by setting, yielding two segments: personal and professional. In 2016, the largest segment in the total blood glucose meter market was the personal segment. Personal blood glucose meters are used by individuals who manage their diabetes outside of the professional setting...

  • Diabetes Monitoring
  • United States
  • Diabetes Prevalence

Description The lancet and lancing device market can be segmented by setting, yielding two segments: personal and professional. In 2016, the largest segment in the total lancet and lancing device market was the personal segment. Personal lancets and lancing devices are used by individuals who use personal meters to perform self-monitoring...

  • Diabetes Monitoring
  • Point Of Care Testing
  • United States

Description The U.S. blood glucose test strip market can be segmented by setting, yielding two segments: personal and professional. In 2016, the largest segment in the total blood glucose test strip market was the personal segment. Personal test strips are used by individuals who use personal meters to perform self-monitoring of...

  • Diabetes Monitoring
  • United States

Description The U.S. continuous glucose monitoring (CGM) market can be segmented by setting, yielding two segments: professional CGM and personal CGM. In 2016, the largest segment in the total CGM market was the personal CGM segment. Growth is expected to continue over the forecast period and will be driven by favorable reimbursement,...

  • Diabetes Monitoring
  • United States

Segments Covered in this Procedure Volume Research This market study focuses specifically on the volume of procedures. It includes analysis of procedures. This data outlines the exact growth rates for procedures. If you’re interested in seeing the trends in procedures to formulate your market sizing and forecasts this is the most...

  • Insulin
  • Diabetes Monitoring
  • United States

The value of the blood glucose meter market increased in 2015 and modest growth is expected to continue over the forecast period, driven by increasing unit sales and limited by ASP erosion. Unit sales growth will be driven by the increasing patient population and as a result, increasing number of diabetics that are testing their blood glucose...

  • Diabetes Monitoring
  • Europe

The value of the blood glucose test strip market increased in 2015 and modest growth is expected to continue over the forecast period, driven by increasing unit sales and limited by ASP erosion. Unit sales growth will be driven by the increasing patient population and as a result, increasing number of diabetics that are testing their blood...

  • Diabetes Monitoring
  • Europe

The European traditional blood glucose monitoring market is comprised of the blood glucose meter segment, the blood glucose test strip segment, and the lancet and lancing device segment. In 2015, the largest segment in the traditional blood glucose monitoring market was the test strip market, which represented nearly 98% of the total market...

  • Diabetes Monitoring
  • Point Of Care Testing
  • Europe

The European CGM market comprises the CGM system segment and the CGM sensor segment. The business model for CGM is similar to traditional blood glucose meters, where the CGM system is the base equipment and the majority of sales are made from the disposable sensor component, which is replaced every three to seven days depending on the manufacturer....

  • Diabetes Monitoring
  • Europe

Diabetes mellitus is a multifaceted disease that yields various approaches in terms of diagnosis, treatment and drug delivery. Products for maintenance and treatment of diabetes can be of high volume and low cost or of relatively low volume and high cost. The U.S. diabetes monitoring, treatment and drug delivery market increased in value in...

  • Insulin
  • Diabetes Monitoring
  • United States
  • Diabetes Prevalence

Diabetes mellitus is a disease characterized by hyperglycemia, or an excessive amount of blood glucose. Diabetes results when there are defects in insulin production or usage, or a combination of the two. Insulin is a hormone that allows cells to convert sugar (glucose), starch and other food into energy. It is produced in the beta...

  • Diabetes Monitoring
  • Diabetes
  • Insulin Delivery
  • Insulin
  • Drug Delivery
  • Europe

About self-monitoring blood glucose device Self-monitoring blood glucose device is a home-based electronic device. It consists of a glucose sensor and a transmitter that transmits information about glucose levels through radiowaves from the sensor to a receiver, where it is displayed. The regular usage of self-monitoring blood glucose...

  • Diabetes Monitoring
  • World
  • APAC
  • Diabetes Prevalence
  • Elderly Population